https://mcmillan.ca/wp-content/uploads/2020/05/profile-default-mobile.jpg

Sasa Jarvis is a respected capital markets and securities lawyer. Her practice focuses primarily on corporate and securities law matters, including financings of public and private companies, mergers and acquisitions, corporate governance issues, and continuous disclosure obligations.

Representing clients in various industries, including technology, life sciences, and regulated industries, Sasa works extensively with clients in the mining and cannabis sectors.

As part of her mining practice, Sasa advises public and private companies with respect to property option agreements, acquisitions of mineral properties, asset purchase and sale transactions, as well as technical disclosure.

Sasa advises public and private clients in the cannabis industry on transactional and corporate compliance matters, primarily with a view to going public, raising funds, and continuing to comply with disclosure and other requirements. She has assisted clients in the cannabis space since the firm established its dedicated practice in 2016.



Representative Matters

  • Acted for Bright Minds Biosciences Inc. in connection with its prospectus and listing on the Canadian Securities Exchange, 2021
  • Acted for Bright Minds Biosciencess Inc. in an overnight marketed short form prospectus for gross proceeds of $25.9 million, March 2021
  • Acted for MJIC, Inc. in connection with its reverse takeover to form ManifestSeven Holdings Corporation, September 2020
  • Acted for Turmalina Metals Corp. in an overnight marketed prospectus offering for gross proceeds of $8,500,000, February 2020
  • Acted for Turmalina Metals Corp. in connection with its prospectus and listing on the TSX Venture Exchange, 2019
  • Acted for Aurora Cannabis Inc. in connection with its acquisition of Whistler Medical Marijuana Corporation valued at $175,000,000.
  • Acted for Harvest One Cannabis Inc. (formerly Harvest One Capital Inc.) in its qualifying transaction involving the acquisition of 100% of the issued and outstanding shares of each of United Greeneries Holdings Ltd. from MMJ PhytoTech Limited and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly subsidiary of MMJ PhytoTech Limited, and a related brokered $25,000,000 subscription receipt offering
  • Acts for various TSX Venture Exchange and Canadian Securities Exchange listed issuers in brokered and non-brokered debt and equity financings
  • Acts for companies completing going public transactions including reverse takeovers on the TSX Venture Exchange and Canadian Securities Exchange
  • Acts for Capital Pool Companies and businesses in completing “qualifying transactions” pursuant to the TSX Venture Exchange CPC program
  • Acted for VMS Ventures Inc. while Royal Nickel Corporation was purchasing it for a total consideration of $21.1 million, April 2016

Speaking Engagements

“Legislative Update”, Advanced Securities 2020 Series, Continuing Legal Education Society of British Columbia

June 2020

News


Media Mentions


Directorships & Affiliations

  • Past Co-Chair of SOGIC-BC, a section of the Canadian Bar Association in British Columbia
  • Law Society of British Columbia

Education & Admissions

2015
Called to the British Columbia bar
2014
Juris Doctor with Business Law Concentration University of British Columbia
2011
BA, Political Science and Modern European StudiesUniversity of British Columbia

Insights by Sasa Jarvis (14 Posts)

Featured Insight

Proposed Changes to the Promotional Activity Disclosure Requirements: Instrument 51-519

An overview of the proposed Instrument 51-519 from the BC Securities Commission on promotional activity disclosure requirements.

Read More
Jun 30, 2021
Featured Insight

The Canadian Capital Market is Psyched: An Update on the Growing Wave in the Psychedelics Industry

This bulletin provides an overview of the regulations surrounding psychedelics in Canada and psychedelics companies in the Canadian capital markets.

Read More
May 12, 2021
Featured Insight

Exemption for Four Patients Opens Door Further for Therapeutic Use of Psilocybin

A legal update on psychedelics: four Canadians with late stage cancer receive approval to use psilocybin to treat
their end-of-life distress.

Read More
Aug 19, 2020
Featured Insight

Psychedelics and Canada’s Regulatory Landscape

A primer on the emerging psychedelics industry and how it fits into Canada's legal framework.

Read More
Jul 10, 2020
Featured Insight

Stop the Presses: Printing of Disclosure Documents May Be a Thing of the Past

A summary of the proposal by CSA to adopt an "access equals delivery" model for disclosure documents.

Read More
Jan 22, 2020
Featured Insight

CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A

Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions

Read More
Nov 15, 2019
Featured Insight

The Next Phase of Canadian Cannabis: What to Expect in 2019 and Beyond

On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products

Read More
Jun 21, 2019
Featured Insight

Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China

Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China

Read More
Oct 9, 2017
Featured Insight

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

Read More
Sep 8, 2017
Featured Insight

McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators

McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators

Read More
Sep 4, 2017
Featured Insight

Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer

Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer

Read More
Jul 10, 2017
Featured Insight

Compliant at this Time: Canada’s Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Compliant at this Time: Canada's Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis

Read More
Jul 6, 2017
Featured Insight

Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis

Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis

Read More
Apr 17, 2017
Featured Insight

Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions

Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions

Read More
Oct 7, 2015